iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Q4FY23 Review: Jyothy Laboratories: Robust margin recovery

4 May 2023 , 11:16 AM

Jyothy Labs reported Q4FY23 results with EBITDA above IIFL estimates, driven primarily by better than expected performance on the gross margin front (+428bpsYoY). Fabric care and Personal care registered double-digit growth and Household Insecticides returned to positive growth territory after four consecutive quarters of YoY decline. Analysts at IIFL Capital Services have upgraded their EPS estimates by 3% for FY24 and FY25 and have maintained their Buy recommendation on the stock.

Significant beat on margins

Jyothy Labs reported a strong Q4FY23 with a net sales growth of 13% (3% above IIFL estimates) and EBITDA growth of 59% (11% above IIFL estimates). Overall volumes grew 3.3% during the quarter. Fabric care and Personal care posted double digit growths with fabric care leading the way at 20% YoY growth. HI growth was flat YoY (versus -16% in 3Q). EBITDA beat was driven largely by sharp gross margin improvement – up 428bps YoY and 262bps QoQ.

Focus on distribution expansion

Direct reach stood at 1.1mn outlets (1mn in end-FY22) with the company reaching all the villages above 100k population in India directly. Management is focusing on distribution expansion to drive volumes in near term and has implemented ‘Botree’- distributor management system to increase productivity. With consistent drives on availability and offtake-led initiatives on LUPs, Exo-dish wash brand reached its highest-ever market share of 13.8% in CY22, led by strong double-digit volume growth. The company has launched 3 new variants of Lime, Jasmine and Rose in Margo Neem naturals Soap in April 2023.

EPS upgrades

The company has delivered 13% sales growth in FY23, on the back of strong price hikes taken in recent quarters. However, as price hikes anniversarize in next few quarters, sales growth is going to taper down unless volume growth picks up. Management has guided for a double-digit top-line growth for FY24; however, analysts at IIFL Capital Services are building 8% YoY keeping a margin for safety. The company has clocked an EBITDA margin of 14.8% in Q4 and going ahead, analysts at IIFL Capital Services expect FY24 margins to remain at similar levels. 

Related Tags

  • Jyothy Laboratories
  • Jyothy Laboratories Q4
  • Jyothy Labs
  • Jyothy Labs Q4
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

SBI Card Q4 Profit Slips 20%
25 Apr 2025|11:17 PM
HUL Q4 Net Profit Rises to ₹2,493 Crore
25 Apr 2025|10:59 PM
Sensex and Nifty in Red on April 25, 2025
25 Apr 2025|02:08 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.